VITALHUB CORP (VHI.CA) Stock Fundamental Analysis

Canada • Toronto Stock Exchange • TSX:VHI • CA92847V5018

8 CAD
-0.1 (-1.23%)
Last: Feb 9, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to VHI. VHI was compared to 9 industry peers in the Health Care Technology industry. Both the health and profitability get an excellent rating, making VHI a very profitable company, without any liquidiy or solvency issues. VHI is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make VHI suitable for growth and quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • VHI had positive earnings in the past year.
  • VHI had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: VHI reported negative net income in multiple years.
  • VHI had a positive operating cash flow in 4 of the past 5 years.
VHI.CA Yearly Net Income VS EBIT VS OCF VS FCFVHI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

1.2 Ratios

  • With an excellent Return On Assets value of 0.76%, VHI belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
  • VHI has a better Return On Equity (1.08%) than 88.89% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 2.86%, VHI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for VHI is in line with the industry average of 2.16%.
Industry RankSector Rank
ROA 0.76%
ROE 1.08%
ROIC 2.86%
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
VHI.CA Yearly ROA, ROE, ROICVHI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

  • VHI's Profit Margin of 2.88% is amongst the best of the industry. VHI outperforms 100.00% of its industry peers.
  • VHI has a Operating Margin of 12.47%. This is amongst the best in the industry. VHI outperforms 100.00% of its industry peers.
  • VHI's Operating Margin has improved in the last couple of years.
  • With an excellent Gross Margin value of 80.92%, VHI belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
  • VHI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.47%
PM (TTM) 2.88%
GM 80.92%
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
VHI.CA Yearly Profit, Operating, Gross MarginsVHI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VHI is destroying value.
  • Compared to 1 year ago, VHI has more shares outstanding
  • The number of shares outstanding for VHI has been increased compared to 5 years ago.
  • The debt/assets ratio for VHI has been reduced compared to a year ago.
VHI.CA Yearly Shares OutstandingVHI.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
VHI.CA Yearly Total Debt VS Total AssetsVHI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • An Altman-Z score of 3.44 indicates that VHI is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.44, VHI is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • The Debt to FCF ratio of VHI is 0.13, which is an excellent value as it means it would take VHI, only 0.13 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of VHI (0.13) is better than 100.00% of its industry peers.
  • VHI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • With an excellent Debt to Equity ratio value of 0.00, VHI belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.13
Altman-Z 3.44
ROIC/WACC0.33
WACC8.65%
VHI.CA Yearly LT Debt VS Equity VS FCFVHI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 1.94 indicates that VHI should not have too much problems paying its short term obligations.
  • The Current ratio of VHI (1.94) is better than 77.78% of its industry peers.
  • A Quick Ratio of 1.94 indicates that VHI should not have too much problems paying its short term obligations.
  • VHI's Quick ratio of 1.94 is fine compared to the rest of the industry. VHI outperforms 77.78% of its industry peers.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.94
VHI.CA Yearly Current Assets VS Current LiabilitesVHI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • The earnings per share for VHI have decreased strongly by -14.29% in the last year.
  • Looking at the last year, VHI shows a very strong growth in Revenue. The Revenue has grown by 59.34%.
  • Measured over the past years, VHI shows a very strong growth in Revenue. The Revenue has been growing by 46.32% on average per year.
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%

3.2 Future

  • The Earnings Per Share is expected to grow by 70.74% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, VHI will show a very strong growth in Revenue. The Revenue will grow by 27.33% on average per year.
EPS Next Y-6.21%
EPS Next 2Y86.09%
EPS Next 3Y70.74%
EPS Next 5YN/A
Revenue Next Year60.05%
Revenue Next 2Y38.57%
Revenue Next 3Y27.33%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
VHI.CA Yearly Revenue VS EstimatesVHI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M
VHI.CA Yearly EPS VS EstimatesVHI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 133.33, the valuation of VHI can be described as expensive.
  • 100.00% of the companies in the same industry are more expensive than VHI, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 28.03, VHI is valued quite expensively.
  • The Price/Forward Earnings ratio is 33.00, which means the current valuation is very expensive for VHI.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of VHI indicates a rather cheap valuation: VHI is cheaper than 88.89% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.97. VHI is around the same levels.
Industry RankSector Rank
PE 133.33
Fwd PE 33
VHI.CA Price Earnings VS Forward Price EarningsVHI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, VHI is valued cheaper than 100.00% of the companies in the same industry.
  • 100.00% of the companies in the same industry are more expensive than VHI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 41.45
EV/EBITDA 17.54
VHI.CA Per share dataVHI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

  • The decent profitability rating of VHI may justify a higher PE ratio.
  • A more expensive valuation may be justified as VHI's earnings are expected to grow with 70.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y86.09%
EPS Next 3Y70.74%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for VHI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VITALHUB CORP

TSX:VHI (2/9/2026, 7:00:00 PM)

8

-0.1 (-1.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-06
Earnings (Next)03-16
Inst Owners40.16%
Inst Owner ChangeN/A
Ins Owners11.45%
Ins Owner ChangeN/A
Market Cap504.96M
Revenue(TTM)98.17M
Net Income(TTM)2.83M
Analysts81.33
Price Target15.42 (92.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-78.71%
Min EPS beat(2)-129.12%
Max EPS beat(2)-28.31%
EPS beat(4)0
Avg EPS beat(4)-61.43%
Min EPS beat(4)-129.12%
Max EPS beat(4)-28.31%
EPS beat(8)0
Avg EPS beat(8)-58.34%
EPS beat(12)1
Avg EPS beat(12)-46.79%
EPS beat(16)2
Avg EPS beat(16)-54.73%
Revenue beat(2)2
Avg Revenue beat(2)9.95%
Min Revenue beat(2)7.24%
Max Revenue beat(2)12.66%
Revenue beat(4)4
Avg Revenue beat(4)6.3%
Min Revenue beat(4)0.61%
Max Revenue beat(4)12.66%
Revenue beat(8)6
Avg Revenue beat(8)4.15%
Revenue beat(12)10
Avg Revenue beat(12)4.05%
Revenue beat(16)12
Avg Revenue beat(16)4.16%
PT rev (1m)-0.6%
PT rev (3m)-2.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-36.84%
EPS NY rev (1m)0%
EPS NY rev (3m)-44.29%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)4.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.4%
Valuation
Industry RankSector Rank
PE 133.33
Fwd PE 33
P/S 5.14
P/FCF 41.45
P/OCF 39.09
P/B 1.93
P/tB 10.26
EV/EBITDA 17.54
EPS(TTM)0.06
EY0.75%
EPS(NY)0.24
Fwd EY3.03%
FCF(TTM)0.19
FCFY2.41%
OCF(TTM)0.2
OCFY2.56%
SpS1.56
BVpS4.15
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.37
Profitability
Industry RankSector Rank
ROA 0.76%
ROE 1.08%
ROCE 4.19%
ROIC 2.86%
ROICexc 4.95%
ROICexgc N/A
OM 12.47%
PM (TTM) 2.88%
GM 80.92%
FCFM 12.41%
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
ROICexc(3y)5.88%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y132.1%
ROICexc growth 5YN/A
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
F-Score3
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.13
Debt/EBITDA 0.05
Cap/Depr 7.67%
Cap/Sales 0.75%
Interest Coverage 250
Cash Conversion 59.17%
Profit Quality 430.43%
Current Ratio 1.94
Quick Ratio 1.94
Altman-Z 3.44
F-Score3
WACC8.65%
ROIC/WACC0.33
Cap/Depr(3y)9.42%
Cap/Depr(5y)8.61%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.89%
Profit Quality(3y)466.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
EPS Next Y-6.21%
EPS Next 2Y86.09%
EPS Next 3Y70.74%
EPS Next 5YN/A
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
Revenue Next Year60.05%
Revenue Next 2Y38.57%
Revenue Next 3Y27.33%
Revenue Next 5YN/A
EBIT growth 1Y46.83%
EBIT growth 3Y217.15%
EBIT growth 5YN/A
EBIT Next Year76.68%
EBIT Next 3Y40.05%
EBIT Next 5YN/A
FCF growth 1Y-12.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.32%
OCF growth 3YN/A
OCF growth 5YN/A

VITALHUB CORP / VHI.CA FAQ

What is the fundamental rating for VHI stock?

ChartMill assigns a fundamental rating of 6 / 10 to VHI.CA.


What is the valuation status of VITALHUB CORP (VHI.CA) stock?

ChartMill assigns a valuation rating of 6 / 10 to VITALHUB CORP (VHI.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for VITALHUB CORP?

VITALHUB CORP (VHI.CA) has a profitability rating of 7 / 10.


Can you provide the financial health for VHI stock?

The financial health rating of VITALHUB CORP (VHI.CA) is 7 / 10.